Pathstone Holdings
SEM icon

Pathstone Holdings’s Select Medical SEM Stock Holding History

Pathstone Holdings’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,354
Closed -$190K – 2328
2025
Q1 		$190K Buy
+11,354
New +$209K ﹤0.01% 2092
2024
Q4 		– Sell
-14,976
Closed -$281K – 2389
2024
Q3 		$281K Buy
14,976
+145
+1% +$2.78K ﹤0.01% 2010
2024
Q2 		$280K Buy
14,831
+276
+2% +$4.71K ﹤0.01% 1974
2024
Q1 		$236K Buy
+14,555
New +$213K ﹤0.01% 2058

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
8KM
8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return
Hood River Capital Management
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Pathstone Holdings's SEM Position: Q2 2025 in Review

Pathstone Holdings sold out of Select Medical (SEM) in Q2 2025, closing a stake of 11,354 shares — an estimated $190K sold.

Pathstone Holdings first reported a position in SEM in Q1 2024 and held it in 4 quarters. The position peaked at $281K in Q3 2024. 262 funds tracked by Wall St. Rank hold SEM as of Q2 2025.

  • Pathstone Holdings reported no remaining Select Medical position as of Q2 2025 after selling out during the quarter.
  • Pathstone Holdings sold 11,354 Select Medical shares in Q2 2025, an estimated $190K.
  • Pathstone Holdings first reported a position in Select Medical in Q1 2024 and held it in 4 quarters.
  • Pathstone Holdings's Select Medical position peaked at $281K in Q3 2024.
  • 262 funds tracked by Wall St. Rank held Select Medical as of Q2 2025.

Based on Pathstone Holdings's 13F filing for Q2 2025, filed 12 Aug 2025.